Monoclonal antibodies specific for sickle cell hemoglobin

Area of Science:

• Biotechnology
• Immunology
• Hematology

Background:

• Hemoglobin S is the cause of sickle cell disease.
• Distinguishing hemoglobin S from normal hemoglobin A is crucial for diagnosis.
• Existing methods may lack the sensitivity or specificity for certain applications.

Purpose of the Study:

• To develop novel monoclonal antibodies specific to hemoglobin S.
• To characterize the binding affinity and specificity of these antibodies.
• To evaluate the utility of these antibodies in cell analysis and identification.

Main Methods:

• Immunization of mice with peptide-protein conjugates encoding the beta chain of hemoglobin S.
• Isolation and characterization of hybridoma cell lines producing monoclonal antibodies.
• Immunoassays, flow cytometry, and immunoblotting for specificity and sensitivity testing.

Main Results:

• Two hybridoma cell lines producing monoclonal antibodies against hemoglobin S were successfully generated.
• Antibodies demonstrated high specificity for hemoglobin S and the immunizing peptide.
• Antibody detected one sickle cell (AS) among a million normal cells (AA) and enabled flow cytometry analysis.
• Immunoblotting confirmed definitive identification of hemoglobin S over other variants.

Conclusions:

• Novel monoclonal antibodies with high specificity and sensitivity for hemoglobin S have been developed.
• These antibodies are valuable tools for precise detection and analysis of hemoglobin S.
• Potential applications include sensitive diagnostics and research in sickle cell disease.